What is Streptococcus Agalactiae?
Streptococcus agalactiae is a very common tribe of bacteria, which is completely harmless to most healthy people. Bacteria colonies can live in digestive, reproductive and urinary tract without causing any negative health problems. However, in newborn children and adults with a weakened immune system, Streptococcus agalactiae may become a source of serious, potentially life -threatening infections. Bacteria can cause serious damage to the lungs, brain and heart unless immediately recognized and treated. Intravenous (IV) antibiotics are usually effective in killing colonies Streptococcus agalactiae and promoting rapid recovery.
The newborn is particularly exposed to the high risk of Streptococcus agalactiae infections because their immune systems are not yet strong enough to fight pathogens. Pregnant mothers who carry bacteria in their lower reproductive tractions can transmit infections to their children as they are delivered. Patients with cancer receiving immuneIt can also experience active infections with a system that suppresses chemotherapy and people who have chronic diseases such as HIV.
The most common initial symptoms of Streptococcus Agalactiae infection in children include fatigue, irritability, poor appetite and fever. As for the lungs and hearts, permanent cough and shortness of breath may occur. If the bacteria reaches the brain, it can cause seizures in the future and set the soil for developmental disorders. Adult patients may experience fever, weakness, skin rashes and urinary tract infections.
A simple blood test can confirm or exclude Streptococcus agalactiae in patients who show symptoms. Physical tests and diagnostic scanning are useful in determining which organs are involved and to what extent. If a doctor suspects brain infection, he may decide to collect a sample of fluid from the spine to check the laboratoryHo testing.
Most cases of Streptococcus Agalactiae infection can be treated if they are discovered early. IV penicillin or similar antibiotics are able to stop the spread of infection and kill existing pathogens in the bloodstream. Newborns and adult patients may be hospitalized during treatment to ensure that they receive sufficient fluids and support for persistent symptoms. If lungs, brain or heart are involved, patients may require oxygen therapy and constant vital monitoring. Most patients receiving early treatment can recover in less than one month.
Advances in preventive medicine and testing techniques help reduce the frequency of new infections Streptococcus agalactiae. Before giving birth, pregnant women are usually examined for bacterial colonies. Antibiotics administered before and during work can also reduce the chances of handing over the infection to the child.